Muya Xiong

机构：Shanghai Institute of Materia Medica · ORCID：0000-0003-4639-5303

发表论文 23 篇 · 总被引 722 次 · h-index 14

代表论文

What coronavirus 3C‐like protease tells us: From structure, substrate selectivity, to inhibitor design (2021 · Medicinal Research Reviews · 被引 139)
Structure-based development and preclinical evaluation of the SARS-CoV-2 3C-like protease inhibitor simnotrelvir (2023 · Nature Communications · 被引 115)
Structural basis of ligand binding modes at the human formyl peptide receptor 2 (2020 · Nature Communications · 被引 103)
In Silico Screening-Based Discovery of Novel Inhibitors of Human Cyclic GMP–AMP Synthase: A Cross-Validation Study of Molecular Docking and Experimental Testing (2020 · Journal of Chemical Information and Modeling · 被引 70)
Bispecific prodrug nanoparticles circumventing multiple immune resistance mechanisms for promoting cancer immunotherapy (2021 · Acta Pharmaceutica Sinica B · 被引 54)
USP28 and USP25 are downregulated by Vismodegib in vitro and in colorectal cancer cell lines (2020 · FEBS Journal · 被引 39)